GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (FRA:79O) » Definitions » Change In Receivables

NuGen Medical Devices (FRA:79O) Change In Receivables : €0.12 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is NuGen Medical Devices Change In Receivables?

NuGen Medical Devices's change in receivables for the quarter that ended in Sep. 2024 was €-0.10 Mil. It means NuGen Medical Devices's Accounts Receivable increased by €0.10 Mil from Jun. 2024 to Sep. 2024 .

NuGen Medical Devices's change in receivables for the fiscal year that ended in Dec. 2023 was €-0.07 Mil. It means NuGen Medical Devices's Accounts Receivable increased by €0.07 Mil from Dec. 2022 to Dec. 2023 .

NuGen Medical Devices's Accounts Receivable for the quarter that ended in Sep. 2024 was €0.02 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. NuGen Medical Devices's Days Sales Outstanding for the three months ended in Sep. 2024 was 4.12.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NuGen Medical Devices's liquidation value for the three months ended in Sep. 2024 was €-8.27 Mil.


NuGen Medical Devices Change In Receivables Historical Data

The historical data trend for NuGen Medical Devices's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices Change In Receivables Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Receivables
0.10 -0.11 0.04 -0.07

NuGen Medical Devices Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 0.02 0.17 0.04 -0.10

NuGen Medical Devices Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuGen Medical Devices  (FRA:79O) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

NuGen Medical Devices's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.016/0.354*91
=4.12

2. In Ben Graham's calculation of liquidation value, NuGen Medical Devices's accounts receivable are only considered to be worth 75% of book value:

NuGen Medical Devices's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=6.215-14.612+0.75 * 0.016+0.5 * 0.224
=-8.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuGen Medical Devices Change In Receivables Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


NuGen Medical Devices Business Description

Traded in Other Exchanges
Address
18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Europe followed by Asia, North America and others.

NuGen Medical Devices Headlines

No Headlines